Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Trichomonas vaginalis 20s proteasome catalytic subunits denaturing gel proteomics

ABSTRACT: Sample 7 = top band, sample 8 = middle band, sample 9 = lowest band. Purified tv20S was incubated with 2uM MV151 probe overnight and imaged. The three bands visualized were excised and trypsin digested for proteomics. The data was searched against the T. vaginalis proteome.

INSTRUMENT(S): Orbitrap Eclipse

ORGANISM(S): Trichomonas Vaginalis (ncbitaxon:5722)

SUBMITTER: Samuel Myers Anthony O'Donoghue

PROVIDER: MSV000092082 | MassIVE | Thu Jun 01 15:51:00 BST 2023

SECONDARY ACCESSION(S): PXD042632

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Similar Datasets

Recombinant trichomonas vaginalis proteasome native gel digest

Project description:Recombinant proteasome (expressed in S. frugiperda) was loaded to native gel. Gel band was visualized via silver stain and excised for proteomics. MS data was searched against a fasta file including the proteome of S. frugiperda and the cloned T. vaginalis proteins.

2023-05-26 | MSV000092044 | MassIVE

Identification of Trichomonas vaginalis 5-nitroimidazole resistance targets

Project description:We aimed to delineate mechanisms of T. vaginalis resistance using transcriptome profiling of metronidazole (MTZ)-resistant and sensitive T. vaginalis clinical isolates.

2023-04-30 | GSE227448 | GEO

Transcription profiling of Trichomonas vaginalis cultured in the low-iron and high-iron conditions

Project description:Transcriptional changes of Trichomonas vaginalis cultured in the low-iron and high-iron conditions.

2010-07-24 | E-MTAB-126 | biostudies-arrayexpress

Genome-wide map of H3K4me3 and H3K27Ac in the protozoan parasite Trichomonas vaginalis

Project description:In this study, we investigated genome-wide transcriptional and epigenetic responses of T. vaginalis to histone deacetylase (HDAC) inhibitors.

2017-04-03 | GSE89662 | GEO

Trichomonas vaginalis

Project description:Trichomonas vaginalis Genome sequencing

| PRJNA280779 | ENA

Trichomonas vaginalis

Project description:Trichomonas vaginalis Transcriptome or Gene expression

| PRJNA345042 | ENA

Trichomonas vaginalis

Project description:Trichomonas vaginalis Transcriptome or Gene expression

| PRJNA849385 | ENA

20S Proteasome as a Drug Target in Trichomonas vaginalis.

Project description: Not available

| S-EPMC6811414 | biostudies-literature

Trichomonas vaginalis

Project description:Genome-wide map of H3K4me3 and H3K27Ac in the protozoan parasite Trichomonas vaginalis

| PRJNA352855 | ENA

Trichomonas vaginalis

Project description:Trichomonas vaginalis is a sexually transmitted infection that causes vaginitis and increases the risk of HIV transmission. We are interested in the secreted and membrane glycoproteins of Trichomonas because they are likely involved in pathogenesis and may include novel vaccine targets. Four mass spectrometric methods (identification of all parasite proteins, glycoprotein enrichment with the plant lectin Concanavalin A, peptide:N-glycanase treatment to identify occupied N-glycans sites, and analysis of N-terminal peptides) were used to identify >300 Trichomonas secreted and membrane proteins. The first group of these proteins, which were present in multiple genome copies and had homologs in diverse eukaryotes, included 1) those involved in the N-glycan-dependent quality control protein folding in the ER lumen, 2) metalloproteases, serine proteases, cysteine proteases, and other lysosomal enzymes, and 3) transporters and membrane-associated cyclases. The second group of secreted and membrane proteins were, for the most part, encoded by single copy genes, unique to Trichomonas, and missing N-terminal signal peptides. The latter observation is despite evidence that the signal peptide peptidase functions normally in Trichomonas. As the unique secreted and membrane proteins of Trichomonas were often large and lacked features that make it easy to choose vaccine candidates, alternative strategies for vaccination and/or therapy are discussed.

2022-02-22 | PXD000699 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data